• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫测定中使交叉反应分子干扰最小化的方法。

Approaches to minimizing interference by cross-reacting molecules in immunoassays.

作者信息

Miller J J, Valdes R

机构信息

Department of Pathology, University of Louisville School of Medicine, KY 40292.

出版信息

Clin Chem. 1991 Feb;37(2):144-53.

PMID:1993317
Abstract

Here we review techniques useful in eliminating or reducing interferences caused by molecules that cross-react in immunoassays. The biochemical rationale for using these techniques is discussed. Examples are taken from recent studies aimed at reducing interferences caused by endogenous molecules such as digoxin-like immunoreactive factors or steroid hormones. In this context the role of protein-binding of cross-reacting molecules is also considered. Immunoassay ligand selectivity can be inherently limited by the heterogeneity of the antigenic response or by the structural similarity of epitopes on multiple ligands. Certain empirical approaches have proved useful in maximizing the analytical specificity of immunoassays. These approaches include isolating the relevant ligands before immunoassay, adjusting the kinetic or equilibrium conditions used during the assays, and developing more specific antisera. The physicochemical properties of the cross-reacting molecule best dictate which technique(s) to use. The approaches discussed here are general and apply to minimizing interference caused by a wide variety of both endogenous and exogenous cross-reacting molecules.

摘要

在此,我们回顾了有助于消除或减少免疫分析中交叉反应分子所引起干扰的技术。文中讨论了使用这些技术的生化原理。实例取自近期旨在减少内源性分子(如地高辛样免疫反应因子或甾体激素)所引起干扰的研究。在此背景下,还考虑了交叉反应分子的蛋白质结合作用。免疫分析配体的选择性可能会因抗原反应的异质性或多种配体上抗原决定簇的结构相似性而固有地受到限制。某些经验方法已证明有助于使免疫分析的分析特异性最大化。这些方法包括在免疫分析前分离相关配体、调整分析过程中使用的动力学或平衡条件,以及开发更具特异性的抗血清。交叉反应分子的物理化学性质最能决定使用哪种技术。本文讨论的方法具有普遍性,适用于将各种内源性和外源性交叉反应分子所引起的干扰降至最低。

相似文献

1
Approaches to minimizing interference by cross-reacting molecules in immunoassays.免疫测定中使交叉反应分子干扰最小化的方法。
Clin Chem. 1991 Feb;37(2):144-53.
2
Clinical repercussions of analytical interferences due to aldosterone antagonists in digoxin immunoassays: an assessment.醛固酮拮抗剂对地高辛免疫检测分析干扰的临床影响评估。
Ther Drug Monit. 2010 Apr;32(2):169-76. doi: 10.1097/FTD.0b013e3181cdc93e.
3
Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors.
Clin Chem. 1986 Aug;32(8):1506-9.
4
Specificity of immunoassays. II. Heterogeneity of specificity of antibodies in antisera used for steroid immunoassay and the selective blocking of less specific antibodies, including a new method for the measurement of immunoassay specificity.免疫测定的特异性。II. 用于类固醇免疫测定的抗血清中抗体特异性的异质性以及对特异性较低抗体的选择性阻断,包括一种测量免疫测定特异性的新方法。
Eur J Nucl Med. 1979 Jun 1;4(3):159-70. doi: 10.1007/BF00620480.
5
Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone.雅培 ARCHITECT 临床化学和免疫分析系统:地高辛检测不受螺内酯、坎利酮及其常见代谢产物坎利酮的干扰。
Ther Drug Monit. 2011 Feb;33(1):128-31. doi: 10.1097/FTD.0b013e3181fd4c30.
6
Impact of interferences including metabolite crossreactivity on therapeutic drug monitoring results.干扰物(包括代谢物交叉反应)对治疗药物监测结果的影响。
Ther Drug Monit. 2012 Oct;34(5):496-506. doi: 10.1097/FTD.0b013e318261c2c9.
7
Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
Am J Clin Pathol. 2002 Jul;118(1):132-40. doi: 10.1309/3VNP-TWFQ-HT9A-1QH8.
8
Effect of Chinese medicines Chan Su and Lu-Shen-Wan on serum digoxin measurement by Digoxin III, a new digoxin immunoassay.中药蟾酥和六神丸对采用新型地高辛免疫分析法Digoxin III测定血清地高辛的影响。
Ther Drug Monit. 2008 Feb;30(1):95-9. doi: 10.1097/FTD.0b013e31816457c7.
9
Digoxin--issues and controversies.地高辛——问题与争议
Clin Chem. 1986 Jan;32(1 Pt 1):5-12.
10
Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups.
Clin Chem. 1996 Mar;42(3):373-9.

引用本文的文献

1
Retrospective Approach to Evaluate Interferences in Immunoassay.评估免疫测定干扰的回顾性方法
EJIFCC. 2017 Oct 10;28(3):224-232. eCollection 2017 Oct.
2
High Estradiol Levels During Postmenopause - Pitfalls in Laboratory Analysis.绝经后雌二醇水平升高——实验室分析中的陷阱
Geburtshilfe Frauenheilkd. 2015 Sep;75(9):941-944. doi: 10.1055/s-0035-1557815.
3
Estimation of estradiol in mouse serum samples: evaluation of commercial estradiol immunoassays.测定小鼠血清样本中的雌二醇:商业雌二醇免疫分析方法的评估。
Endocrinology. 2011 Nov;152(11):4443-7. doi: 10.1210/en.2011-1501. Epub 2011 Sep 20.
4
Interferences in immunoassay.免疫测定中的干扰因素。
Clin Biochem Rev. 2004 May;25(2):105-20.